AEON stapler non-inferior to Tri-Staple with preloaded buttress material in achieving haemostasis and maintaining staple-line integrity
FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technology
No increased risk of mental health issues among those using semaglutide for weight loss
No association between GLP-1s and suicide
Journal watch 4/09/2024
REBORN study: How to prioritise patients for BMS leading to the appropriate selection
Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investment
Pneumonia and respiratory causes the largest causes of long-term mortality after BMS
Blocking circulating protein interferon-γ pathway could lead to potential treatment for metabolic liver disease
Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD
